Passio Biomaterials sp. z o.o.
Research and experimental development on biotechnology
Financials
Revenue history (in k)
Filing timeliness
2 of 6 financial statements were filed late (the longest delay 174 days for 2022).
- 202514/07/2026
- 202415/07/2025
- 202312/07/2024
- 202205/01/2024
- 202129/11/2022
- 202014/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Bartłomiej Jan Kałużny age 52 | 2,500 | $67,531.06 | 20% |
Anna Maria Klucz age 47 | 9,428 | $254,673.15 | 75.424% |
Others | 572 | $15,451.11 | 4.576% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Was a VAT taxpayer from 2017-03-31 to 2024-10-28.
Reason for removal: Art. 96 ust. 9a pkt 3 (VAT returns showing no transactions filed for 6 consecutive months or 2 quarters)
Debt
2 closed proceedings recorded in KRZ history.
| Registration date | Proceeding type | Status | |
|---|---|---|---|
| Jan 19, 2026 | Discontinued enforcement proceedings | Closed | |
| Dec 29, 2025 | Discontinued enforcement proceedings | Closed |
Public aid
5 public aid cases recorded, with a total value of $4,596.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 29, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | PREZYDENT MIASTA BYDGOSZCZ | |
| Mar 20, 2019 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $112$112 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Mar 20, 2019 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $61$61 | Prezes Zakładu Ubezpieczeń Społecznych |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Inventionbio S.A. | $17,762,977.76 | inventionbio.pl | ||
| Medicofarma Biotech S.A. | $314,882.33 | medicofarmabiotech.pl | ||
| Frontline Biosciences S.A. | $219,186.29 | frontlinebiosciences.com | ||
| Luna Laboratory sp. z o.o. | $61,894.23 | lunalab.pl | ||
| Genomtec S.A. | $54,746.36 | genomtec.com | ||
| Stenocoat sp. z o.o. | $36,665.21 | stenocoat.com | ||
| Immbionic sp. z o.o. | $31,756.23 | immbionic.com.pl | ||
| Passio Human Microbiome sp. z o.o. | $1,856.58 | passiohumanmicrobiome.com | ||
| SONO Live sp. z o.o. | – | sonolive.eu | ||
| Selvita S.A. | – | selvita.com |
Change history
| Date | Event | |
|---|---|---|
| 2022-12-29 | Address change (Ul. Bydgoskich Przemysłowców 6, 85-862, Bydgoszcz → Ul. Wojska Polskiego 65a/215, 85-825, Bydgoszcz) | |
| 2019-02-28 | Share capital increase (1,000,000.00 PLN → 1,250,000.00 PLN) | |
| 2019-02-28 | PKD change (Removed: 68.20.Z; Added: 46.46.Z) | |
| 2018-04-23 | Share capital increase (500,000.00 PLN → 1,000,000.00 PLN) | |
| 2018-03-06 | Share capital increase (360,000.00 PLN → 500,000.00 PLN) |
FAQ
Last updated: 2026-07-15